Targeting T and B Lymphocytes in Inflammatory Bowel Diseases: Lessons from Clinical Trials

医学 免疫学 炎症性肠病 T细胞 溃疡性结肠炎 炎症 美罗华 抗体 免疫系统 疾病 内科学
作者
Romana R. Gerner,Alexander R. Moschen,Herbert Tilg
出处
期刊:Digestive Diseases [Karger Publishers]
卷期号:31 (3-4): 328-335 被引量:20
标识
DOI:10.1159/000354687
摘要

Both innate and adaptive immunity play an important role in the pathogenesis of inflammatory bowel diseases (IBDs). There is strong evidence that especially activated T cells initiate and perpetuate inflammation and tissue destruction. The increased numbers of CD4<sup>+</sup> T cells in the intestinal wall of IBD patients may be explained by enhanced influx/activation and decreased apoptosis of these cells. Several studies have demonstrated that the gut-homing receptors CCR9 and α4β7 are selectively induced on T cells during their priming in intestinal inflamed sites. Whereas targeting of activated CD4<sup>+</sup> T cells by specific antibody strategies or neutralization of key T-cell cytokines such as IL-2 or IFN-&#947; has not been effective in human IBD, blocking migration of activated leukocytes, e.g. T cells into the inflamed tissue by specific antibodies such as vedolizumab, seems highly effective. Recently it could also been demonstrated that administration of antigen-specific regulatory T cells to patients with refractory Crohn's disease was not only well tolerated but showed promising results. The role of B cells in human IBD is less clear. B-cell depletion has so far only been studied in ulcerative colitis where rituximab (anti-CD20) therapy failed. Therefore, although the therapeutic targeting of ‘inflammatory' T and B cells was not successful in IBD, especially T cells remain key players in IBD. Targeting either T-cell migration or the use of regulatory T cells appears as the most promising ‘T-cell-directed' therapies in the future.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
LaTeXer应助林林林林采纳,获得50
刚刚
不想发布了新的文献求助10
1秒前
1秒前
2秒前
2秒前
2秒前
llll发布了新的文献求助10
3秒前
ailsa完成签到 ,获得积分20
4秒前
大碗公发布了新的文献求助10
4秒前
6秒前
10秒前
11秒前
SciGPT应助hyue采纳,获得10
11秒前
Lip发布了新的文献求助50
13秒前
卫wei完成签到,获得积分10
13秒前
大碗公完成签到,获得积分10
14秒前
汉堡包应助多情的飞绿采纳,获得30
15秒前
16秒前
隐形曼青应助大根猫采纳,获得10
16秒前
17秒前
Liu完成签到,获得积分10
17秒前
17秒前
fsy完成签到,获得积分10
17秒前
19秒前
小鱼干完成签到,获得积分20
19秒前
wwwssss完成签到 ,获得积分10
19秒前
yarkye完成签到,获得积分10
20秒前
20秒前
20秒前
weidongwu发布了新的文献求助10
20秒前
llll发布了新的文献求助10
21秒前
22秒前
22秒前
好的哥完成签到,获得积分10
23秒前
上官若男应助KingXing采纳,获得10
24秒前
张大宝完成签到,获得积分10
24秒前
顾矜应助Richard采纳,获得10
24秒前
两块二毛发布了新的文献求助10
25秒前
26秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988838
求助须知:如何正确求助?哪些是违规求助? 3531250
关于积分的说明 11252914
捐赠科研通 3269838
什么是DOI,文献DOI怎么找? 1804820
邀请新用户注册赠送积分活动 881943
科研通“疑难数据库(出版商)”最低求助积分说明 809028